flected by the ratio of IL-10 and TNF-in the lung. Background -The adult respiratory dis- (Thorax 1997;52:442-446) tress syndrome (ARDS) may be regarded as an example of an uncontrolled or exKeywords: adult respiratory distress syndrome, intercessive inflammatory response in which leukin 10, tumour necrosis factor . tumour necrosis factor (TNF-) has been proposed to play a central role. Interleukin
Southmead Hospital, Bristol. The study was 10 standards (courtesy of DNAX) were added in duplicate and incubated for two hours at approved by the ethics committees at both centres. The extent of injury to trauma patients 37°C. Biotinylated rat anti-human IL-10 monoclonal antibody (Pharmingen) was used was assessed by the Injury Severity Score (ISS). 20 An ISS score of >15 was used to define as a detecting antibody. IL-10 levels were determined by colorimetric analysis using avidin multiple trauma. Sepsis syndrome was defined according to the criteria of Bone et al. 21 Patients peroxidase. This assay had a detection limit of 1 pg/ml. were defined as having ARDS or as being at risk of ARDS on the basis of the Lung Injury Extracellular unbound immunoreactive TNF-was quantified by a double sandwich Score (LIS) as defined by Murray. 4 Chest radiographic infiltrates, pulmonary compliance, the ELISA as previously described 22 (courtesy of Celltech, Slough, UK). ratio of arterial oxygen concentration and positive end expiratory pressure were scored on a scale of 1-4. The LIS was calculated by dividing the total score by the number of criteria used,  
The data, which were not normally distributed, a score of more than 2.5 being used to define ARDS. The median LIS score for the at risk were compared using two sample, one tailed Mann-Whitney U/Wilcoxon ranked sum test patients was 1.5 (range 1-2) and that of the patients with ARDS was 3.0 (range 2.67-3.67). analysis and Spearman rank correlation coefficient (Minitab package). A p value of <0.05 Patients were studied within 24 hours of arrival on the ITU and all were mechanically ventil-was considered significant. ated at the time of study. There were 16 patients at risk of ARDS and 10 with ARDS, with no significant difference between the two groups Results
Twenty six patients were investigated within in the time between onset of illness and bronchoscopic examination.
24 hours of arrival on the ITU and plasma and BAL fluid were obtained. Sufficient alveolar macrophages for culture were obtained from at least five subjects in each group. There was   () Each bronchoscopic examination was per-no significant difference in the time between the onset of illness and admission to the ITU for formed through an indwelling endotracheal tube. Bronchoalveolar lavage (BAL) was per-either patient group. The statistical significance observed between patients with ARDS and formed in the right middle lobe. All the bronchoscopies were done by one physician (AM). those at risk of ARDS in terms of BAL fluid concentrations of IL-10 was dependent upon The chilled BAL fluid was strained through a single layer of coarse gauze to remove mucus the inclusion of four at risk subjects who presented with perforated bowel. However, there clumps and then spun at 400 g for 10 minutes to recover cells. The resultant cell free fluid was were no discriminating features which would permit exclusion of these subjects other than stored at −70°C until analysis. The alveolar macrophages were purified by negative se-their presentation. The remaining data, although influenced by these four patients, were lection with magnetic beads using granulocytespecific anti-CD66b (Serotec) and T cell-spe-not reliant upon them for statistical significance. cific anti-CD3 antibodies (Dynal). Minimal binding of alveolar macrophages was observed. The resultant population was more than 98% pure and 95% viable (estimated by Diffquick - There was a trend towards an increase in the staining and Trypan Blue exclusion). Alveolar macrophages were cultured for 24 hours at concentration of TNF-in the BAL fluid of the 10 patients with ARDS compared with 37°C in 5% carbon dioxide in the presence or absence of lipopolysaccharide (LPS) in those at risk of ARDS (n=10; fig 1) and there serum-free RPMI 1640 medium (Sigma) supplemented with 100 U/ml penicillin and 100 g/ml streptomycin (Gibco). Supernatants were stored at −70°C until required.
At the time of bronchoscopy, 50 ml of blood was taken from each subject. Plasma was separated by centrifugation and stored at −70°C for future analysis. We have found no differences in the immunoreactivity of samples whether analysed immediately or after such storage for up to two years.
  -10  -Extracellular immunoreactive IL-10 was quan- 
of patients with ARDS and those at risk of supernatants of patients with ARDS and those at risk of ARDS (n=5) in response to a dose range of ARDS (n=5) in response to a dose range of lipopolysaccharide (LPS) or with medium alone (control). lipopolysaccharide (LPS) or with medium alone (control).
detectable in the BAL fluid of both patients was a similar finding for spontaneous and LPS-with ARDS and those at risk of ARDS (p<0.01 induced TNF-production by alveolar macro-and p<0.001, respectively). There was no corphages (n=5; fig 2) . These data did not reach relation between concentrations of IL-10 or statistical significance. Plasma concentrations TNF-and survival (not shown). of TNF-were similar for both groups.
  - -10    -10   IL-10 levels detectable in the plasma of patients
The relative concentrations of TNF-and ILwith ARDS (n=10) were significantly lower 10 in the BAL fluid of both patient groups than the IL-10 levels detected in the plasma were calculated. The ratio of TNF-to IL-10 of at risk patients (n=16) (median difference in the BAL fluid of patients with ARDS was −17.5, 95% CI −52.4 to 1.31, p<0.05). Sim-3.52 compared with a ratio of only 0.85 in at ilarly, IL-10 levels detectable in the BAL fluid risk patients (median difference 1.44, 95% CI of patients with ARDS were significantly lower 0.07 to 5.01, p<0.01). than in the BAL fluid of at risk patients (median difference −32.1, 95% CI −47.5 to 2.3, p<0.05; fig 3) . There was no difference in ILDiscussion 10 production by alveolar macrophages (n=5)
It is widely recognised that ARDS results from between the two groups (fig 4) . the interplay of complex inflammatory processes, and pro-inflammatory cytokines may      have an important role. Previous reports have -10  -   suggested a pathogenic role for TNF-in The levels of TNF-in the BAL fluid were ARDS, 9 although this has recently been discompared with the corresponding levels of IL-puted. 23 The current findings demonstrate a 10 for each patient using the Spearman rank tendency towards increased TNF-production correlation. There was a significant positive by alveolar macrophages from ARDS patients correlation between IL-10 and TNF-levels compared with at risk patients, and this is reflected in the BAL fluid, although it did not reach statistical significance. By contrast, concentrations of IL-10 in the BAL fluid and plasma of subjects with ARDS are significantly lower than in those at risk of ARDS. Capillary leakage is a potential source of mediators in the lung compartment of patients with lung injury and ARDS, but IL-10 levels in the BAL fluid were greater than in the corresponding plasma values, although the difference was not significant. This finding, in addition to the detection of IL-10 in the alveolar macrophage supernatants, suggests that IL-10 in the BAL fluid is probably intrapulmonary in origin. The data presented here have identified the alveolar may be responsible for the differences seen group.bmj.com on April 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from in the BAL fluid. These data illustrate the 10, 12 13 and it is assumed that such tightly regulated homeostatic mechanisms are crucial to imbalance between pro-inflammatory and antiinflammatory factors in the development of the prevention of pathological consequences of inflammation. We have previously shown that ARDS.
IL-10 has been shown to inhibit pro-in-IL-10 can inhibit TNF-production by human alveolar macrophages and peripheral blood flammatory cytokine release 16 and to downregulate class II MHC and B7 which are monocytes 22 acting, at least in part, by downregulating gene transcription of TNF-mRNA important molecules in antigen presentation 24 25 and is thus presumed to have a largely anti-in response to LPS. This study demonstrates a positive correlation between IL-10 and TNFinflammatory role. In vitro IL-10 inhibits several functions of monocytes and macrophages, production in both patient groups, but there is a clear distinction between the two groups including production of TNF-and IL-1, 16 and in animal models of endotoxaemia IL-10 since there is a larger ratio of TNF-protein to IL-10 protein in the BAL fluid from patients is produced and reduces LPS toxicity. 26 In the clinical setting IL-10 levels are increased in with ARDS, favouring a pro-inflammatory process. The data presented highlight the diseases such as septicaemia, the highest plasma levels of IL-10 being present in those with importance of the imbalance between pro-inflammatory and anti-inflammatory activity in septic shock 19 and rheumatoid arthritis 27 where its inhibition by anti-IL-10 antibody in synovial ARDS. Longitudinal studies of at risk subjects with repeated lavage are required to be anything cell cultures leads to increases in active TNFand a potential exacerbation of the in-more than speculative on the role of IL-10 in this clinical scenario. flammation. This suggests that IL-10 may have a protective effect in inflammatory disease. This finding is supported by a recent study by Lynne 
